Status:
UNKNOWN
Prodromal Parkinsonian Features in GBA1 Mutation Carriers
Lead Sponsor:
Shaare Zedek Medical Center
Conditions:
Gaucher Disease, Type 1
Healthy
Eligibility:
All Genders
40-75 years
Brief Summary
Objective of the trial. To define a sub-population which is at increased risk of developing Parkinson, beyond the fact of carrying Gaucher; in this sub-population the investigators shall conduct a com...
Detailed Description
The carriers, the healthy people and the Gaucher patients will undergo a number of non-invasive tests, which test the pre-Parkinson signs. The tests are based on various sense tests, blood tests, mea...
Eligibility Criteria
Inclusion
- Willing to participate
Exclusion
- PD patients
- Dementia
Key Trial Info
Start Date :
May 16 2017
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2025
Estimated Enrollment :
600 Patients enrolled
Trial Details
Trial ID
NCT05253560
Start Date
May 16 2017
End Date
December 31 2025
Last Update
November 24 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Michal Becker- Cohen
Jerusalem, Please Select..., Israel, 9103102